Paraneoplastic syndromes are rare complications that can develop as a result of cancer. While cancer is often associated with well-known symptoms, these syndromes occur when the body’s immune system mistakenly attacks healthy cells instead of targeting the neoplasm or abnormal growths. This misguided defense mechanism leads to a range of side effects that vary in severity. Paraneoplastic syndromes can serve as an initial warning sign of cancer or manifest spontaneously without a known cause. Regardless of how they arise, these syndromes are intricate in nature, encompassing different categories, combinations, and impacts.
Endocrine Paraneoplastic Syndromes
Paraneoplastic syndromes can be classified into different types, one of which is the endocrine type. This particular type of paraneoplastic syndrome is characterized by the secretion of hormones, peptides, and cytokines by neoplasms. These secretions can trigger a response in the body that mimics the symptoms of metastasis, leading to a misdiagnosis or delayed diagnosis.
It is important to note that while endocrine paraneoplastic syndromes can occur at any stage of cancer, their presence in individuals with malignant tumors often indicates a poor prognosis and lower chances of survival.
Types of Neurological Syndromes Associated with Lung Cancer
Paraneoplastic neurological syndromes (PNS) are commonly observed in individuals diagnosed with lung cancer. A study conducted on a group of lung cancer patients aged between 52 and 72 revealed that around 64 percent of them experienced PNS. These syndromes can manifest as classical conditions like sensory neuropathy or non-classical conditions, which can make diagnosis confirmation quite challenging. Some individuals affected by PNS also develop onconeural antibodies, further complicating the diagnostic process.